Becker's ASC Review

11 ASC MANAGEMENT USPI added 61 ASCs in 2020, plans to gain up to 40 more this year: 10 things to know By Laura Dyrda D allas-based United Surgical Partners Inter- national expects big growth in 2021. Ronald Rittenmeyer, CEO of USPI's par- ent company Tenet, outlined the importance of its ASC segment and where growth is headed in the next year during a presentation at the JPMorgan Healthcare Conference. Ten things to know: 1. In 2020, USPI reported 102 percent year-over- year surgical volume growth before the pandemic; in April surgeries dropped to 20 percent of 2019 levels. By the end of the year, USPI centers report- ed surgical volume at 95 percent of 2019 volumes. 2. In 2019, adjusted EBITDA for USPI was 33 percent; in 2021, the company estimated adjusted EBITDA will hit 45 percent. 3. In 2019, USPI added 61 ASCs including a 45-center acquisition from SurgCenter Develop- ment. e company reported around $210 million in EBITDA generated by the centers acquired from SurgCenter Development. USPI expects a 10 percent estimated return on invested capital by year three. 4. Seventy-three centers began new service lines such as orthopedics, spine, robotics and bariatrics. 5. USPI added more than 3,700 physicians to its medical staff last year. 6. In 2021, USPI plans to deploy more than $150 million in planned acquisition capital with the potential for more if the right opportunity arises. 7. It plans to add 25 to 40 ASCs through tuck-in acquisitions and de novo centers. 8. e company expects 6 percent-plus growth in same-store surgical revenue in the next year. 9. USPI has almost 350 facilities in 33 states. 10. In 2019, USPI reported $2.2 billion in net revenue and has a three-year goal of 10 percent to 15 percent EBITDA growth. n Surgery Partners reports $1.86B in 2020 revenue: 11 things to know By Laura Dyrda Nashville, Tenn.-based Surgery Partners reported full-year revenue for 2020 of $1.86 billion on Jan. 11. Eleven updates: 1. The company also reaffirmed its 2020 full-year adjusted EBITDA guidance in the range of $250 million to $260 million. 2. Surgery Partners reported 116 ASCs and 17 short-stay surgical hospi- tals in its portfolio to end 2020. Its locations span 30 states. 3. More than 4,000 Surgery Partners-affiliated physicians treat 600,000- plus patients per year at the company's centers. 4. Case mix at Surgery Partners' ASCs is 38 percent orthopedics, 25 percent ophthalmology, 19 percent gastroenterology and 18 percent other procedures such as ENT and general surgery. 5. More than 50 percent of the company's net revenue comes from musculoskeletal procedures. 6. In 2020, Surgery Partners added robotic technology to 11 ASCs and now has 30 centers with robots. 7. Cardiology is on the horizon, with more than 60 percent of Surgery Partners facilities having the potential to add cardiology cases. 8. Surgery Partners has a patient net promoter score of 94, higher than the scores for Apple and Costco. 9. In 2020, the company closed a lab and sold selected anesthesia as- sets and Optical GPO. 10. Surgery Partners made 10 acquisitions in 2020 for around $160 million. 11. In 2021, Surgery Partners plans to deploy more than $100 million in capital. n 2 eye surgery centers join Florida group By Carly Behm T wo eye surgery centers merged with Fort Myers, Fla.-based Quigley Eye Specialists, according to a Jan. 13 report from Fort Myers Florida Weekly. Port Charlotte, Fla.-based St. Lucy's Eye Surgery Center and Community Eye Care, both in Port Charlotte, are owned and operated by Joseph Sapadafora, DO, and Eric Schaible, MD. Dr. Spadafora has more than 30 years of experience in ophthalmology and is the medical director of Community Eye Center, the report said. Dr. Schaible is the eye research director at Community Eye Center and has 24 years of experience in the field. The practices join 16 other locations under Quigley Eye Specialists. n

• Cover